|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 37/00 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 2848258 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14191582.7 |
| Date of filing the European patent application | 2006-10-24 | |
| (97) | Date of publication of the European application | 2015-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-13 |
| (46) | Date of publication of the claims translation | 2018-02-26 |
| (30) | Number | Date | Country code |
| 730435 P | 2005-10-26 | US | |
| 742125 P | 2005-12-02 | US |
| (72) |
Lowe, Phil, CH
Gram, Hermann, DE
Jung, Thomas, CH
Wright, Timothy, US
Mundel, Trevor, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Šeiminės Viduržemio jūros karštligės gydymas su anti-IL-1 beta antikūnais |
| Treatment of familial Mediterranean Fever with anti IL-1beta antibodies |
| Payment date | Validity (years) | Amount | |
| 2025-09-19 | 20 | 347.00 EUR |